Production and evaluation of multi-epitope recombinant protein of | 59076
Journal of Infectious Diseases & Preventive Medicine

Journal of Infectious Diseases & Preventive Medicine
Open Access

ISSN: 2329-8731

Production and evaluation of multi-epitope recombinant protein of leishmania infantum in serological diagnosis of visceral leishmaniasis by Elisa

Joint Event on Infection Congress 2020 & Tropical Diseases 2020

February 24-25, 2020 | Berlin, Germany

Marzieh Taherzadeh, Morad Ali Foladvand and Bahram Kazemi

Bushehr University of Medical Sciences, Iran
Shahid Beheshti University of Medical Sciences, Iran

Posters & Accepted Abstracts: J Infect Dis Prev Med

Abstract :

Background: Visceral leishmaniasis, which is Mediterranean in Iran, is caused by leishmania infantum. The importance of this disease is due to the untimely death of the untreated patients, the difficulty in treating patients with immunodeficiency and high numbers of children involved. Therefore, attempts to diagnose rapidly with high sensitivity and specificity and timely treatment are inevitable. The present study was conducted for the first time in Iran to increase the sensitivity and specificity of the diagnostic ELISA test for human visceral leishmaniasis using a multiepitope antigen. Methods: A gene fragment composed of eight different epitopes from the major antigens of leishmania infantum was developed and sent to Biomatic Company for synthesizing. The multiepitope recombinant sequence was cloned and expressed in pET 32a and E.coli BL21 (DE3) respectively. The antigen was identified by the SDS page and then verified with the western blot. Purification was performed by affinity chromatography Ni-NTA resin (sigma). Finally, pure MRP was coated in microtiter plate and the sensitivity & specificity detection of anti-leishmaniasis antibodies in the serum of patients was evaluated. Results: Intact cloned plasmid with 7kb weight, intact uncloned plasmid with 5.5kb and as expected the insert sequence fraction with 1.2kb on a 1% agarose gel was detected. Then, bacterial expression lysate on acrylamide gel 12%, was shown recombinant antigen band with 63 KDa size marker. The protein band was confirmed in the next step by western blot with the same molecular weight. Sensitivity and specificity of the antigen were calculated 93.1% and 77.14% respectively in ELISA serodiagnosis test. Discussion: MRP contained epitopes of several important L. infantum antigens was successfully expressed in the prokaryotic system and results of its potential serodiagnosis of HVL were well documented. According to reaction between the MRP and the specific IgG in humans, it could be concluded that the main objectives of the present study are best achieved. More optimization have been postponed for future study due to the time limitation. Further studies are required to evaluate the immunogenicity in animal models and to verify the immuno-reactivity of MRP as a new diagnostic antigen.